fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
LOG IN
SIGN UP

Fincash » Search » Biocon Ltd

Biocon Ltd

Updated on July 8, 2020

Stock/Share Code - BIOCON

Biocon is engaged in the manufacture of biotechnology products and research services.

Below is the details of BIOCON Biocon Ltd

Market Cap₹42,564 Cr.
Current Price ₹437.6 as on 14 Jul 20
52 Week High / Low Price₹367.8 / ₹211.05
Face Value₹5
Stock P/E135.04
Book Value₹62.81
Dividend Yield0.14 %
ROCE4.82 %
ROE4.79 %
Sales Growth (3yrs)7.81 %
SectorPharmaceuticals
IndustryPharmaceuticals - Indian - Bulk Drugs & Formln
Listed onBSE  AND  NSE
Company WebsiteCompany Website
Pros: Company has reduced debt. Company is virtually debt free.
Cons: Stock is trading at 5.65 times its book value The company has delivered a poor growth of 5.54% over past five years. Company has a low return on equity of 5.35% for last 3 years. Earnings include an other income of Rs.378.40 Cr.

Biocon Ltd Price Chart

Biocon Ltd Price Chart

Biocon Ltd Peer Comparison in Pharmaceuticals

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Qtr Sales Var % Sales Qtr Rs.Cr. ROCE %
1. Sun Pharma.Inds. ₹164.15 28.53 ₹113,788.46 Cr. 0.63 ₹399.84 Cr. -2.03 14.25 8184.94 11.19
2. Dr Reddy's Labs ₹3,983.15 33.39 ₹67,652.81 Cr. 0.49 ₹781.1 Cr. 71.52 10.41 4448.90 12.42
3. Cipla ₹632.3 33.79 ₹52,256.4 Cr. 0.46 ₹245.95 Cr. -33.02 -0.63 4376.19 10.94
4. Aurobindo Pharma ₹809.35 16.67 ₹43,690.51 Cr. 0.40 ₹705.45 Cr. -2.26 11.87 5895.00 18.45
5. Biocon 135.04 ₹42,564 Cr. 0.14 ₹102.2 Cr. 17.19 4.24 482.40 4.82
6. Torrent Pharma. ₹35.95 39.00 ₹39,979.07 Cr. 0.72 ₹314 Cr. 121.13 4.85 1946.00 12.66
7. Cadila Health. ₹353.8 25.02 ₹35,278.17 Cr. 1.02 ₹373.9 Cr. -26.54 1.68 3638.10 15.35
8. Alkem Lab ₹2,474.9 24.26 ₹27,056.36 Cr. 0.97 ₹381.98 Cr. 88.60 13.26 2181.84 16.58

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Biocon Ltd Fundamentals

Quarterly Results

Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31.

Standalone Figures in Rs. Crores

Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020
Sales -574605592648423457443463481524501482
YOY Sales Growth %-17.46%-2.09%-8.65%3.48%-26.38%-24.47%-25.11%-28.59%13.72%14.71%13.06%4.24%
Expenses -488532536561373395403420418434424439
Material Cost %42.45%44.95%42.46%43.57%46.00%45.24%42.83%42.68%39.95%41.13%41.19%44.28%
Employee Cost %16.73%15.94%17.62%17.25%15.23%15.81%16.49%17.16%17.10%16.21%17.51%18.64%
Operating Profit867356885061404263907743
OPM %15%12%9%14%12%13%9%9%13%17%15%9%
Other Income2646373122210064521076610698
Interest100-001110000
Depreciation373333322223232324242525
Profit before tax748560872501377971146132158117
Tax %27%20%27%17%8%13%8%0%23%20%24%13%
Net Profit546844722301207370112106121102
EPS in Rs0.460.580.370.611.910.510.620.300.950.901.020.86
NotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotes

Profit & Loss

The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement.

Standalone Figures in Rs. Crores

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019TTM
Sales -8779121,1631,5611,5561,9382,2022,2422,3022,5882,4192,8851,988
Sales Growth %3.10%3.99%27.48%34.22%-0.34%24.57%13.65%1.78%2.69%12.43%-6.52%19.24%
Expenses -6796968681,0101,2221,5331,7291,8131,8801,9962,1012,4991,715
Material Cost %44.62%44.29%47.06%40.98%47.65%46.33%45.08%44.85%42.90%40.00%43.38%43.57%
Manufacturing Cost %12.07%11.39%10.10%9.05%11.00%9.48%10.43%10.76%11.56%10.49%12.33%12.50%
Employee Cost %8.01%9.00%8.57%9.36%12.35%11.80%12.15%12.78%14.07%14.18%16.96%17.79%
Other Cost %12.74%11.63%8.91%5.28%7.55%11.52%10.86%12.50%13.14%12.46%14.17%12.77%
Operating Profit198216295552334405473428422592318386274
OPM %23%24%25%35%21%21%21%19%18%23%13%13%14%
Other Income388-22635767396112927999125316378
Interest3521211124131
Depreciation69748090949512412814015113614798
Profit before tax514114276517304347409428559536306552553
Tax %15%2%10%11%16%21%21%16%34%3%22%11%
Net Profit435112248459256276324361369519238493441
EPS in Rs3.550.852.013.752.002.082.562.983.074.331.994.103.73
Dividend Payout %12%54%28%20%39%54%31%28%27%12%25%12%

Compounded Sales Growth

  • 10 Years:: 12.20%
  • 5 Years:: 5.54%
  • 3 Years:: 7.81%
  • TTM:: 11.35%

Compounded Profit Growth

  • 10 Years:: 5.06%
  • 5 Years:: 0.57%
  • 3 Years:: 3.13%
  • TTM:: 0.34%

Return on Equity

  • 10 Years:: 21.98%
  • 5 Years:: 37.31%
  • 3 Years:: 29.88%
  • 1 Year:: 30.91%

Balance Sheet

A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios.

Standalone Figures in Rs. Crores

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Share Capital -50100100100100100100100100100300300600
Equity Capital50100100100100100100100100100300300600
Reserves1,2781,2751,4661,8471,9962,1072,3182,4845,8976,4416,4396,8156,937
Borrowings14416419216916113112182370134133714
Other Liabilities -2743375064885636756796677327948551,054770
Trade Payables103106142200251265268301394450580644521
Advance from Customers6284764368139
Other liability items165228356285305404407363332336262401249
Total Liabilities1,7461,8762,2642,6042,8203,0133,2183,3337,0987,4697,7278,2408,311
Fixed Assets -6797146786806858519499148949389031,101793
Gross Block8839921,0271,1171,2131,4581,7301,8321,9342,1292,2372,581
Accumulated Depreciation2032773484385286067819181,0411,1911,3341,480
CWIP653858103825110258172241318254152
Investments4773474194866576194931653,8533,8884,1994,0164,953
Other Assets -5257771,1091,3351,3961,4921,6742,1962,1792,4022,3072,8692,413
Inventories168195245275340359358406505540562802535
Trade receivables226296384418445427495555504798740902573
Cash Equivalents867721040179204621643383197356375
Loans n Advances1272844072040596876121295264531277
Other asset items-3-4-4412530467550538406386544278653
Total Assets1,7461,8762,2642,6042,8203,0133,2183,3337,0987,4697,7278,2408,311

Cash Flows

Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow.

Standalone Figures in Rs. Crores

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Cash from Operating Activity -265116231355162348186125208186355110
Profit from operations265183347571361416489432472647371440
Receivables49-69-98-33-2718-65-65-16-30875-174
Inventory-17-27-50-30-66-1815-49-69-35-22-240
Payables-443175-805760-7331407671199
Loans Advances-15-8-124-22-106-56-152-1430000
Direct taxes-14-5-19-51-58-71-93-83-205-121-88-137
Other operating items00000000-112-74-5121
Exceptional CF items000020000000
Cash from Investing Activity --266-75-120-147-196-8751145-313104-553315
Fixed assets purchased-96-84-77-123-108-243-154-58-220-228-173-258
Fixed assets sold002200001030
Investments purchased-2,136-1,874-1,942-1,843-1,586-1,600-1,211-1,997-3,435-2,801-839-3,275
Investments sold1,7062,0101,8751,7631,5111,6251,3182,2163,5252,5013423,386
Interest received13442122252764124
Dividends received142210172828251126211436
Invest in subsidiaries0-6-5-12-710-0-00000
Loans to subsidiaries-27-135-40000-237-198-96-204-215
Shares acq cancelled00000000000289
Other investing items272-101646291027187-100650263328
Cash from Financing Activity -2-43-37-100-111-147-187-15873-238-55-208
Proceeds from shares0000000010192732
Proceeds from borrowings38184068000304000
Repayment of borrowings00-6-29-19-30-11-37-14-239-1-67
Interest paid fin-3-4-1-1-1-1-1-1-1-4-1-3
Dividends paid-30-50-60-70-90-100-150-100-2110-69-69
Other financing items-3-7-10-6-9-16-26-20-15-15-10-101
Net Cash Flow1-273108-14611450112-3252-252217

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Ratios

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
ROCE %17%15%17%27%14%16%17%17%10%8%4%5%
Debtor Days941181209810480829080113112114
Inventory Turnover5.515.045.296.015.065.546.155.875.054.964.394.23

Announcements & News

Recent Announcements

How to Invest in Mutual Funds SIP Online?

  1. Open Free Investment Account for Lifetime at Fincash.com.
  2. Complete your Registration and KYC Process
  3. Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest! Get Started
  4. Invest in Mutual Funds which invests in Biocon Ltd & Get More Returns than Bank Deposit

Disclaimer:
All efforts have been made to ensure the information provided here is accurate as per time to time filling by company to exchanges. However, no guarantees are made regarding correctness of data. Investors are advised to validate/check information with exchanges or companies website before making any investment decisions.